Miriam Grazia Ferrara

1PUBLICATIONS
7CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Oct 23, 2021
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned.

Lorenzo Belluomini, Silvia Teresa Riva, Michele Simbolo

Pageof 1

Frequent Collaborators

1 joint publications

Lorenzo Belluomini

1 joint publications

Michele Simbolo

1 joint publications

Ilaria Trestini

1 joint publications

Alice Avancini

1 joint publications

Emilio Bria

1 joint publications

Aldo Scarpa

1 joint publications

Sara Pilotto

Frequent Collaborators

1 joint publications

Lorenzo Belluomini

1 joint publications

Michele Simbolo

1 joint publications

Ilaria Trestini

1 joint publications

Alice Avancini

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

8.1K
See more related videos

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

8.1K
See more related videos